Recruitment and retention of participants for biobanks, personalised medicine and clinical trials are critical as these activities support the provision of critical resources, generation of enabling data and ensure new interventions can be evaluated. Poor participant retention rates can be attributed to participant engagement; particularly obtaining, recording, and auditing consent. Inefficient paper-based systems yield high costs. A plethora of bespoke, opaque and poorly supported electronic systems exist but these do not facilitate adaptive designs. Since 45% of clinical trials require costly extensions, the inability to effectively engage participants and obtain consent is highly detrimental. Biobanks and translational genomics must also support new demands and emergent findings.
Participant-centric approach provides an interface that ensures patients can give, review and change their consent preferences whilst also allowing two-way interactions between clinicians and participants. Participants are therefore fully engaged with the process, the retention rate is increased retention and management costs are reduced.
Benefits of the Dynamic Consent approach to trial management include:
Easy collection, storage and retrieval of consent preferences
On-going communication for improved recruitment, participant engagement and reduced drop-out rates
Easy identification of participants that can be approached for additional trials
Enables adaptive trial designs through a simple re-consenting procedure
Legally compliant data collection that is efficient and secure
Benefits to participants include:
Enhanced interaction and on-going participation due to easy access to information
Information delivered according to an individual’s preferences
Fully informed and prepared for each stage of the trial
Enabling, as able to review and revise consent preferences
Suitable for visually impaired, and those with hearing or learning difficulties